Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module

Key Facts

Boston Scientific Corporation (NYSE: BSX) has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module when it is used to visualize and track the FARAWAVE™ Nav Pulsed Field Ablation (PFA) Catheter for the treatment of patients with paroxysmal and persistent atrial fibrillation (AF).
The FARAVIEW technology and the FARAWAVE Nav catheter expand the capabilities of the FARAPULSE™ PFA System through integration with our cardiac mapping system.
"Through this study, we hope to identify the procedural benefits of the FARAWAVE Nav catheter, which can both map and ablate, alongside technology that allows for magnetically-tracked, dynamic visualization of a patient's cardiac anatomy and catheter configuration."
"This study seeks to build on the compelling performance of the FARAPULSE PFA System by providing an integrated mapping and navigation experience for physicians," said Brad Sutton, M.D., chief medical officer, AF Solutions, Boston Scientific.